Astellas Pharma Europe Ltd.
Clinical trials sponsored by Astellas Pharma Europe Ltd., explained in plain language.
European subsidiary of Astellas, a global pharmaceutical company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Could a Once-Daily pill replace Twice-Daily dosing for young transplant patients?
Disease control CompletedThis study tested whether children who had received an organ transplant (kidney, liver, heart, lung, or intestine) could safely switch from taking tacrolimus twice a day (Prograf) to a once-daily version (Advagraf). The goal was to see if the once-daily pill provided similar drug…
Phase: PHASE2 • Sponsor: Astellas Pharma Europe Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New Non-Hormonal pill eases menopause hot flashes in german women
Symptom relief CompletedThis study looks at how well fezolinetant, a non-hormonal tablet, helps reduce hot flashes and night sweats in menopausal women in Germany. About 105 women whose doctor already prescribed fezolinetant will take the tablet and complete virtual surveys over 6 months. The goal is to…
Sponsor: Astellas Pharma Europe Ltd. • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC